# FDA Inspection 1298166 - Hybio Pharmaceutical Co., Ltd. (longhua) - December 05, 2025

Source: https://www.keypedia.com/records/fda_inspections/hybio-pharmaceutical-co-ltd-longhua/225b6810-e3fc-44ca-b93a-2bca6d8883bb
Source feed: FDA_Inspections

> FDA Inspection 1298166 for Hybio Pharmaceutical Co., Ltd. (longhua) on December 05, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1298166
- Company Name: Hybio Pharmaceutical Co., Ltd. (longhua)
- Inspection Date: 2025-12-05
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1298166 - 2025-12-05](https://www.keypedia.com/records/fda_inspections/hybio-pharmaceutical-co-ltd-longhua/7115d1c0-549b-4736-93a0-04f76d509b5c)

Company: https://www.keypedia.com/companies/hybio-pharmaceutical-co-ltd-longhua/2b0b20d6-aed0-403f-819f-fe664b314d59

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c